News
A Swiss collaboration has been designated a member of the WHO's CoViNet network
Launched in early 2024, the CoronaVirus Network (CoViNet) aims to detect, monitor and carry out in-depth genetic analyses of coronaviruses and their variants in humans and animals. The IVI is now also a member.
Avian influenza
Research project: Vaccination of zoo birds against highly pathogenic viruses of the avian influenza (H5N1).
Releases
Java script is required to display press releases. If you are unable or unwilling to activate Java script you may use the link below to access the Federal Administration News Portal, where you can read the announcements.
In focus
Improved COVID-19 vector vaccine candidate
In a recent publication, scientists at the Institute of Virology and Immunology (IVI) and the University of Bern report on a Vesicular Stomatitis Virus (VSV)-vectored COVID-19 vaccine candidate.
 web.png)
The Swiss Rabies Centre
As the National Reference Laboratory for Rabies, the Swiss Rabies Centre at the Institute of Virology and Immunology (IVI) is responsible for laboratory diagnosis of rabies in humans and animals.
Blog - Young researchers from the IVI
Robin Avanthay : «The goal was to develop a novel mucosal vaccine against influenza A virus and assess its efficacity in the pig model. »
Transfer of immunological veterinary medicinal products to Swissmedic
On 1 January 2023, responsibility for the authorisation, variation, batch release, market surveillance and licences for importing individual batches of immunological veterinary medicinal products was transferred from the Institute of Virology and Immunology (IVI) to Swissmedic.
In cooperation with Vetsuisse Faculty
www.ivi.unibe.ch